Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer-MedSci.cn

Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

Chour, A; Denis, J; Mascaux, C; Zysman, M; Bigay-Game, L; Swalduz, A; Gounant, V; Cortot, A; Darrason, M; Fallet, V; Auclin, E; Basse, C; Tissot, C; Decroisette, C; Bombaron, P; Giroux-Leprieur, E; Odier, L; Brosseau, S; Creusot, Q; Gueçamburu, M; Meersseman, C; Rochand, A; Costantini, A; Gaillard, CM; Wasielewski, E; Girard, N; Cadranel, J; Lafitte, C; Lebossé, F; Duruisseaux, M

Duruisseaux, M (通讯作者)，Hosp Civils Lyon, Louis Pradel Hosp, Resp Dept & Early Phase, Canc Inst, 59 Blvd Pinel, F-69500 Lyon, France.

Abstract

Introduction: Sequential anti-programmed cell death protein 1 (PD-1) or anti-programmed death-ligand 1 (PD-L1) followed by small targeted therapy use ......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

科室

工具

服务